A recent analysis by the Kaiser Family Foundation finds that Medicare recipients taking Revlimid for cancer could end up paying, on average, $11,538 out of pocket for the drug in 2016, even if the medicine is covered by their Medicare Part D plan. Carmine Galasso/MCT/Landov hide caption

toggle caption
Carmine Galasso/MCT/Landov

For best quality of life, many cancer patients who can't be cured might do best to forgo chemo and focus instead on pain relief and easing sleep and mood problems, a survey of caregivers suggests. iStockphoto hide caption

toggle caption
iStockphoto

What If Chemo Doesn't Help You Live Longer Or Better?

  • Download
  • <iframe src="https://www.npr.org/player/embed/425654509/425654510" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Retired California school teacher Mikkel Lawrence sits with his cat, Max. Lawrence has hepatitis C and has struggled to afford the medicine he needs to treat it. April Dembosky/KQED hide caption

toggle caption
April Dembosky/KQED

A look inside the factory in Kundl, Austria, where Sandoz, a unit of Novartis, makes biosimilar drugs. Novartis hide caption

toggle caption
Novartis

FDA Decision Signals New Competition For Some Of The Costliest Drugs

  • Download
  • <iframe src="https://www.npr.org/player/embed/388668910/392142527" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Reid Kennedy, materials manager at San Francisco General Hospital, stands next to racks of saline solution. He has had to carefully manage the hospital's supply of saline during this shortage. Mark Andrew Boyer/KQED hide caption

toggle caption
Mark Andrew Boyer/KQED

Shortage Of Saline Solution Has Hospitals On Edge

  • Download
  • <iframe src="https://www.npr.org/player/embed/323679204/324480082" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Don Wright runs at an indoor track at the Maplewood Community Center in North Saint Paul, Minn. Ariana Lindquist for NPR hide caption

toggle caption
Ariana Lindquist for NPR

Targeted Cancer Drugs Keep Myeloma Patients Up And Running

  • Download
  • <iframe src="https://www.npr.org/player/embed/172098789/172298062" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript